Get the Stockscreener App
3.02
3.82%
-0.12
After Hours:
3.08
0.06
+1.99%
Adverum Biotechnologies Inc stock is traded at $3.02, with a volume of 79,947.
It is down -3.82% in the last 24 hours and up +22.27% over the past month.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
See More
Previous Close:
$3.14
Open:
$3.08
24h Volume:
79,947
Relative Volume:
0.48
Market Cap:
$63.37M
Revenue:
-
Net Income/Loss:
$-94.11M
P/E Ratio:
-0.5025
EPS:
-6.01
Net Cash Flow:
$-86.06M
1W Performance:
-14.20%
1M Performance:
+22.27%
6M Performance:
-37.60%
1Y Performance:
-57.16%
1-Day Range:
$2.95
$3.08
1-Week Range:
$2.95
$3.59
52-Week Range:
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Name
Adverum Biotechnologies Inc
Sector
Industry
Phone
(650) 649-1004
Address
100 CARDINAL WAY, REDWOOD CITY, CA
Compare ADVM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
3.02 | 69.46M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Apr-30-24 | Initiated | H.C. Wainwright | Buy |
| Jul-07-22 | Upgrade | Truist | Hold → Buy |
| Jul-23-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-03-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-29-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Apr-29-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-29-21 | Downgrade | Truist | Buy → Hold |
| Dec-16-20 | Initiated | UBS | Neutral |
| Nov-12-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jun-26-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| May-05-20 | Upgrade | SunTrust | Hold → Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-16-20 | Initiated | SVB Leerink | Outperform |
| Feb-10-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-10-20 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Oct-15-19 | Reiterated | Chardan Capital Markets | Neutral |
| Sep-13-19 | Reiterated | Chardan Capital Markets | Neutral |
| Jun-14-19 | Resumed | Raymond James | Mkt Perform |
| Nov-02-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-02-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-30-18 | Initiated | SunTrust | Buy |
| Feb-15-18 | Resumed | Piper Jaffray | Overweight |
| Oct-12-17 | Initiated | Raymond James | Outperform |
View All
Adverum Biotechnologies Inc Stock (ADVM) Latest News
Has Adverum Biotechnologies Inc. formed a bullish divergenceMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser
Momentum divergence signals in Adverum Biotechnologies Inc. chartMarket Trend Report & Weekly Top Gainers Trade List - Newser
Will a bounce in Adverum Biotechnologies Inc. offer an exitPortfolio Return Report & Real-Time Buy Zone Alerts - Newser
Can Adverum Biotechnologies Inc. hit a new high this monthStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
What MACD signals say about Adverum Biotechnologies Inc.Weekly Trading Summary & AI Optimized Trade Strategies - Newser
Real time breakdown of Adverum Biotechnologies Inc. stock performanceMarket Volume Report & Daily Entry Point Trade Alerts - Newser
What institutional flow reveals about Adverum Biotechnologies Inc.Weekly Earnings Recap & Expert Approved Trade Ideas - Newser
Adverum Biotechnologies Inc. stock trend outlook and recovery pathJuly 2025 Short Interest & AI Powered Buy and Sell Recommendations - Newser
Analyzing drawdowns of Adverum Biotechnologies Inc. with statistical toolsEarnings Overview Summary & Risk Managed Trade Strategies - Newser
Real time scanner hits for Adverum Biotechnologies Inc. explained2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Using economic indicators to assess Adverum Biotechnologies Inc. potentialIndex Update & Risk Controlled Swing Trade Alerts - Newser
Can a trend reversal in Adverum Biotechnologies Inc. lead to recoveryWeekly Volume Report & Accurate Entry and Exit Point Alerts - Newser
Is a relief rally coming for Adverum Biotechnologies Inc. holdersJuly 2025 Snapshot & Target Return Focused Picks - Newser
Volatility clustering patterns for Adverum Biotechnologies Inc.Trade Exit Summary & AI Forecast for Swing Trade Picks - Newser
Historical volatility pattern of Adverum Biotechnologies Inc. visualizedMarket Growth Summary & High Accuracy Trade Signal Alerts - Newser
can a trend reversal in adverum biotechnologies inc. lead to recoveryPortfolio Growth Summary & Long-Term Growth Stock Strategies - Newser
Will Adverum Biotechnologies Inc. see short term momentumMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
Trexquant Investment LP Sells 77,303 Shares of Adverum Biotechnologies, Inc. $ADVM - Defense World
Will Adverum Biotechnologies Inc. benefit from macro trendsWeekly Investment Report & Fast Gain Stock Tips - Newser
What MACD and RSI say about Adverum Biotechnologies Inc.Weekly Risk Summary & Weekly Setup with High ROI Potential - Newser
Is Adverum Biotechnologies Inc. stock bottoming outWall Street Watch & Long-Term Capital Growth Strategies - Newser
Visual analytics tools that track Adverum Biotechnologies Inc. performanceMarket Rally & Daily Stock Trend Watchlist - Newser
adverum biotechnologies inc. recovery potential after sell off2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
Sentiment analysis tools applied to Adverum Biotechnologies Inc. - Newser
Analyzing Adverum Biotechnologies Inc. with risk reward ratio chartsTrade Exit Summary & Verified Stock Trade Ideas - Newser
Key metrics from Adverum Biotechnologies Inc.’s quarterly data2025 Top Gainers & Stepwise Trade Signal Implementation - Newser
Risk adjusted return profile for Adverum Biotechnologies Inc. analyzedBond Market & Long-Term Growth Portfolio Plans - Newser
Ranking Adverum Biotechnologies Inc. among high performing stocks via tools2025 Buyback Activity & Reliable Entry Point Alerts - Newser
Will Adverum Biotechnologies Inc. rebound enough to break evenTrade Entry Summary & Advanced Swing Trade Entry Plans - Newser
Long term hold vs stop loss in Adverum Biotechnologies Inc.Trade Risk Summary & Reliable Entry Point Trade Alerts - Newser
will adverum biotechnologies inc. see short term momentumPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
Adverum Biotechnologies Inc Stock (ADVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):